Drugs for HIV 2020 and Beyond
This is part of a 4 part series offered in 2020.
At the completion of this activity, the participant will be able to:
Describe the role of newer medications in development for HIV treatment.
Compare and contrast new medications in development for HIV infection
List advantages and disadvantages to injectable and long acting HIV formulations
James McCracken, PharmD
Infectious Diseases Clinical Pharmacist, Jersey Shore University Medical Center
Clinical Assistant Professor, Rutgers University, Ernest Mario School of PharmacY
ACPE UAN # 0042-0000-20-034-H02-P
- 1.50 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.